Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis

Journal of Clinical Investigation

Volumn 97, Issue 12, 1996, Pages 2905-2910

  Goebels, Norbert ^a,b   Michaelis, Dorothea ^a   Engelhardt, Martin ^a,b   Huber, Susanne ^a   Bender, Anke ^a   Pongratz, Dieter ^b   Johnson, Margaret A ^c   Wekerle, Hartmut ^a   Tschopp, Jürg ^d   Jenne, Dieter ^a   Hohlfeld, Reinhard ^a,b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

autoimmune disease; cytotoxicity; inflammation; myopathy; T cell

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; PERFORIN; T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MUSCLE BIOPSY; POLYMERASE CHAIN REACTION; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 8944230654     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118749     Document Type: Article

References (33)

1. Tschopp, J., and M. Nabholz. 1990. Perforin-mediated target cell lysis by cytolytic T lymphocytes. Annu. Rev. Immunol. 8:279-302.
2. Podack, E.R., H. Hengartner, and M.G. Lichtenheld. 1991. A central role of perforin in cytolysis? Annu. Rev. Immunol. 9:129-148.
3. Henkart, P.A. 1994. Lymphocyte-mediated cytotoxicity: two pathway's and multiple effector molecules. Immunity. 1:343-346.
4. Berke, G. 1994. The binding and lysis of target cells by cytotoxic lymphocytes: Molecular and cellular aspects. Annu. Rev. Immunol. 12:735-773.
5. Liu, C.-C., C.M. Walsh, and J.D.-E. Young. 1995. Perforin: Structure and function. Immunol. Today. 16:194-201.
6. Henkart, P.A., M.S. Williams, and H. Nakajima. 1995. Degranulating cytotoxic lymphocytes inflict multiple damage pathways on target cells. Curr. Top. Microbiol. Immunol. 198:75-93.
7. Hohlfeld, R., and A.G. Engel. 1994. The immunobiology of muscle. Immunol. Today. 15:269-274.
8. Engel, A.G., R. Hohlfeld, and B.Q. Banker. 1994. The polymyositis and dermatomyositis syndromes. In Myology. A.G. Engel and C. Franzini-Armstrong, editors. McGraw Hill, New York. 1335-1383.
9. Dalakas, M.C. 1991. Polymyositis, dermatomyositis and inclusion-body myositis. N. Engl. J. Med. 325:1487-1498.
10. Bender, A., N. Ernst, A. Iglesias, K. Dornmair, H. Wekerle, and R. Hohlfeld. 1995. T cell receptor repertoire in polymyositis: Clonal expansion of autoaggressive CD8+ T cells. J. Exp. Med. 181:1863-1868.
11. Emslie-Smith, A.M., and A.G. Engel. 1990. Microvascular changes in early and advanced dermatomyositis: A quantitative study. Ann. Neurol. 27: 343-356.
12. Goebels, N., D. Michaelis, H. Wekerle, and R. Hohlfeld. 1992. Human myoblasts as antigen presenting cells. J. Immunol. 149:661-667.
13. Dupuis, M., E. Schaerer, K.-H. Krause, and J. Tschopp. 1993. The calcium-binding protein calreticulin is a major constituent of lytic granules in cytolytic T lymphocytes. J. Exp. Med. 177:1-7.
14. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
15. Kinoshita, T., T. Imamura, H. Nagai, and K. Shimotohno. 1992. Quantification of gene expression over a wide range by the polymerase chain reaction. Anal. Biochem. 205:231-235.
16. Arahata, K., and A.G. Engel. 1984. Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann. Neurol. 16:193-208.
17. Engel, A.G., and K. Arahata. 1984. Monoclonal antibody analysis of mononuclear cells in myopathies. II. Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann. Neurol. 16:209-216.
18. Arahata, K., and A.G. Engel. 1986. Monoclonal antibody analysis of mononuclear cells in myopathies. III. Immunoelectron microscopy aspects of cell-mediated muscle fiber injury. Ann. Neurol. 19:112-125.
19. Wu, Z., E.R. Podack, J.M. McKenzie, K.J. Olsen, and M. Zakarija. 1994. Perforin expression by thyroid-infiltrating T cells in autoimmune thyroid disorders. Clin. Exp. Immunol. 98:470-477.
20. Liu, C.-C., S. Rafii, A. Granelli-Piperno, J.A. Trapani, and J.D.-E. Young. 1989. Perforin and serine esterase gene expression in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A. J. Exp. Med. 170:2105-2118.
21. Kupfer, A., and S.J. Singer. 1989. Cell biology of cytotoxic and helper T-cell functions. Annu. Rev. Immunol. 7:309-338.
22. Podack, E.R., and A. Kupfer. 1991. T cell effector mechanisms for delivery of cytotoxicity and help. Annu. Rev. Cell Biol. 7:479-504.
23. Yannelli, J.R., J.A. Sullivan, G.L. Mandell, and V.H. Engelhard. 1986. Reorientation and fusion of cytotoxic granules after interaction with target cells as determined by high resolution cinematography. J. Immunol. 136:377-382.
24. Kupfer, A., S.J. Singer, and G. Dennert. 1986. On the mechanism of unidirectional killing in mixtures of two cytotoxic T lymphocytes. Unidirectional polarization of cytoplasmic organelles and the cytoskeleton in the effector cell. J. Exp. Med. 163:489-498.
25. Felzen, G., G. Berke, D. Rosen, R. Coleman, J. Tschopp, J.D.-E. Young, and O. Binah. 1994. Effects of purified perforin and granzyme A from cytotoxic T lymphocytes on guinea pig ventricular myocytes. Cardiovascul. Res. 28: 643-649.
26. Orimo, S., R. Koga, K. Nakamura, M. Arai, M. Tamaki, H. Sugita, I. Nanaka, and K. Arahata. 1994. Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies. Neuromusc. Disord. 4:219-226.
27. Smyth, M.J., J.R. Ortaldo, Y.-I. Shinkai, H. Yagita, M. Nakata, K. Okumura, and H.A. Young. 1990. Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells. J. Exp. Med. 171: 1269-1282.
28. Lundberg, I., J.M. Brengman, and A.G. Engel. 1995. Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy and non-weak controls. J. Neuroimmunol. 63:9-16.
29. Young, L.H.Y., S.V. Joag, L.-M. Zheng, C.-P. Lee, and J.D.-E. Young. 1990. Perforin-mediated myocardial damage in acute myocarditis. Lancet. 336:1019-1021.
30. Hameed, A., K.J. Olsen, L. Cheng, W.M. Fox, R.H. Hruban, and E.R. Podack. 1992. Immunohistochemical identification of cytotoxic lymphocytes using human perforin monoclonal antibody. Am. J. Pathol. 140:1025-1030.
31. Griffiths, G.M., R. Namikawa, C. Mueller, C.-C. Liu, J.D.-E. Young, M. Billingham, and I. Weissman. 1991. Granzyme A and perforin as markers for rejection in heart transplantation. Eur. J. Immunol. 21:687-693.
32. Legros-Maïda, S., A. Soulié, C. Benvenuti, A. Wargnier, N. Vallée, C. Berthou, J. Guillet, M. Sasportes, and N. Sigaux. 1994. Granzyme B and perform can be used as predictive markers of acute rejection in heart transplantation. Eur. J. Immunol. 24:229-233.
33. Lipman, M.L., A.C. Stevens, and T.B. Strom. 1994. Heightened intragraft CTL gene expression in acutely rejecting renal allografts. J. Immunol. 152: 5120-5127.